Previsioni di mercato per la scoperta di anticorpi in Europa fino al 2030 - Analisi regionale - per tipo di anticorpo (anticorpi monoclonali, anticorpi policlonali e altri), natura (umano e umanizzato, chimerico e murino), servizi (Phage Display, ibridoma, animale transgenico, cellula singola e Yeast Display) e utente finale (aziende farmaceutiche e biotecnologiche, laboratori di ricerca e altri)

BMIRE00030736 | Pages: 94 | Biotechnology | Sep 2024 | Type: Regional | Status: Published
Il mercato europeo della scoperta di anticorpi è stato valutato a 8.24.441,11 milioni di dollari nel 2022 e si prevede che raggiungerà 13.29.481,60 milioni di dollari entro il 2030; si stima che registrerà un CAGR del 6,2% dal 2022 al 2030.

La crescente incidenza del cancro guida il mercato europeo della scoperta di anticorpi

Secondo le stime del Global Cancer Observatory (GLOBOCAN) pubblicate nel 2020, si sono verificati 19,3 milioni di casi di cancro in tutto il mondo. Entro gennaio 2030, si stima che la popolazione di sopravvissuti al cancro raggiungerà i 22,1 milioni, il che può essere principalmente associato all\'invecchiamento della popolazione. Polmone, seno, colon-retto, prostata e seno sono tra i tipi di cancro più comunemente segnalati. La crescente incidenza del cancro ha sollevato preoccupazioni in tutto il mondo. Di seguito è riportato l\'elenco dei casi di cancro più comuni segnalati in tutto il mondo nel 2020.

Nuovi casi di cancro nel mondo, nel 2020

Sr. No.

Tipo di cancro

Numero di casi (milioni)

1

Stomaco

1,09

2

Pelle (non melanoma)

1,2

3

Prostata

1,41

4

Colon e retto

1,93

5

Polmone

2,21

6

Seno

2,26

Fonte: Organizzazione mondiale della sanità, febbraio 2020

Il cancro è ormai una malattia legata allo stile di vita, comunemente riscontrata tra le persone con cattive abitudini alimentari e coloro che non svolgono molte attività fisiche. Il consumo frequente di alcol e tabacco aumenta il rischio di sviluppare il cancro. Le malattie infettive croniche nei paesi a basso e medio reddito possono aggravare ulteriormente i fattori di rischio del cancro. Un aumento dell\'incidenza del cancro indica la necessità di trattamenti innovativi contro il cancro. Gli anticorpi monoclonali rappresentano una promettente classe di agenti antitumorali mirati che migliorano la capacità naturale del sistema immunitario di sopprimere l\'attività delle cellule tumorali ed eliminare le cellule tumorali. Anche i coniugati anticorpo-farmaco (ADC) hanno mostrato risultati promettenti nel trattamento del cancro. Inoltre, i progressi nella moderna biotecnologia consentono a ricercatori e aziende di fornire nuovi anticorpi ben progettati, aprendo la strada a trattamenti di successo di vari tipi di cancro. Pertanto, la crescente incidenza di diversi tipi di cancro stimola la crescita del mercato della scoperta di anticorpi.

Panoramica del mercato europeo della scoperta di anticorpi

Il mercato europeo della scoperta di anticorpi è segmentato in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. La regione detiene una quota significativa del mercato globale. Si prevede che registrerà un robusto tasso di crescita nei prossimi anni a causa del crescente utilizzo di anticorpi monoclonali nelle applicazioni di ricerca e sviluppo, nelle terapie contro il cancro e nella gestione dei disturbi immunologici. Inoltre, si prevede che la crescente necessità di sistemi di gestione dei dati dei pazienti, la prevalenza di malattie croniche e le iniziative governative per l\'implementazione di servizi sugli anticorpi forniranno opportunità di crescita per il mercato della scoperta di anticorpi in paesi come Francia, Italia e Spagna.

Fatturato e previsioni del mercato della scoperta di anticorpi in Europa fino al 2030 (miliardi di $ USA)

Segmentazione del mercato della scoperta di anticorpi in Europa

Il mercato della scoperta di anticorpi in Europa è suddiviso in tipo di anticorpo, natura, servizi, utente finale e paese.

In base al tipo di anticorpo, il mercato della scoperta di anticorpi in Europa è suddiviso in anticorpi monoclonali, anticorpi policlonali e altri. Il segmento degli anticorpi monoclonali ha detenuto la quota di mercato della scoperta di anticorpi in Europa più grande nel 2022.

In termini di natura, il mercato della scoperta di anticorpi in Europa è suddiviso in umano e umanizzato, chimerico e murino. Il segmento umano e umanizzato ha detenuto la quota di mercato della scoperta di anticorpi in Europa più grande nel 2022.

In base ai servizi, il mercato europeo della scoperta di anticorpi è suddiviso in phage display, ibridoma, animale transgenico, cellula singola e lievito display. Il segmento phage display ha detenuto la quota di mercato più grande in Europa nella scoperta di anticorpi nel 2022.

In base all\'utente finale, il mercato europeo della scoperta di anticorpi è suddiviso in aziende farmaceutiche e biotecnologiche, laboratori di ricerca e altri. Il segmento delle aziende farmaceutiche e biotecnologiche ha detenuto la quota di mercato più grande in Europa nella scoperta di anticorpi nel 2022.

In base al paese, il mercato europeo della scoperta di anticorpi è suddiviso in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. La Germania ha dominato la quota di mercato europea della scoperta di anticorpi nel 2022.

Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp e Biocytogen Pharmaceuticals Beijing Co Ltd. sono alcune delle aziende leader che operano nel mercato europeo della scoperta di anticorpi.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Antibody Discovery Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Investments in Research & Development

4.1.2 Rising Incidence of Cancer

4.2 Market Restraints

4.2.1 High Cost of Production

4.3 Market Opportunities

4.3.1 Proliferation of Biotechnology Industry in Developing Regions

4.4 Future Trends

4.4.1 Developments for Custom Antibodies

4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Europe Market Analysis

5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Europe Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview

6.2 Monoclonal Antibodies

6.2.1 Overview

6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Polyclonal Antibodies

6.3.1 Overview

6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Antibody Discovery Market Analysis - by Nature

7.1 Overview

7.2 Human and Humanized

7.2.1 Overview

7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Chimeric

7.3.1 Overview

7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Murine

7.4.1 Overview

7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Antibody Discovery Market Analysis - by Services

8.1 Overview

8.2 Phage Display

8.2.1 Overview

8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Hybridoma

8.3.1 Overview

8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Transgenic Animal

8.4.1 Overview

8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Yeast Display

8.5.1 Overview

8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Single Cell

8.6.1 Overview

8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Antibody Discovery Market Analysis - by End User

9.1 Overview

9.2 Pharmaceutical and Biotechnology Companies

9.2.1 Overview

9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Research Laboratories

9.3.1 Overview

9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Antibody Discovery Market - Country Analysis

10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030

10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country

10.1.1.1 UK

10.1.1.1.1 Overview

10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature

10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services

10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User

10.1.1.2 Germany

10.1.1.2.1 Overview

10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature

10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services

10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User

10.1.1.3 France

10.1.1.3.1 Overview

10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature

10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services

10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User

10.1.1.4 Italy

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature

10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services

10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User

10.1.1.5 Spain

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature

10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services

10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User

10.1.1.6 Rest of Europe

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature

10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services

10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Antibody Discovery Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Creative Biolabs Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Evotec SE

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Sartorius AG

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Aragen Life Sciences Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Twist Bioscience Corp

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Biocytogen Pharmaceuticals Beijing Co Ltd

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

 

List of Tables

Table 1. Europe Antibody Discovery Market Segmentation

Table 2. New Cancer Cases Worldwide, in 2020

Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market

Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market

Table 29. Glossary of Terms, Antibody Discovery Market

 

List of Figures

Figure 1. Europe Antibody Discovery Market Segmentation, by Country

Figure 2. Europe Antibody Discovery Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030

Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)

Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)

Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)

Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)

Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)

Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 31. Growth Strategies in the Antibody Discovery Market

  1. Charles River Laboratories International Inc
  2. Creative Biolabs Inc
  3. Evotec SE
  4. Sartorius AG
  5. Aragen Life Sciences Ltd
  6. Twist Bioscience Corp
  7. Biocytogen Pharmaceuticals Beijing Co Ltd
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antibody discovery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe antibody discovery market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440